Morgan Stanley Maintains Overweight on UnitedHealth Group, Raises Price Target to $499
Morgan Stanley analyst Ricky Goldwasser maintains UnitedHealth Group (NYSE:UNH) with a Overweight and raises the price target from $488 to $499.
Oppenheimer Maintains Outperform on UnitedHealth Group, Raises Price Target to $475
Oppenheimer analyst Michael Wiederhorn maintains UnitedHealth Group (NYSE:UNH) with a Outperform and raises the price target from $465 to $475.
RBC Capital Maintains Outperform on UnitedHealth Group, Raises Price Target to $476
RBC Capital analyst Frank Morgan maintains UnitedHealth Group (NYSE:UNH) with a Outperform and raises the price target from $473 to $476.
It’s The Earnings, Stupid
The next big stock market correction has been imminent for, well, months now? Every time the Dow or the Nasdaq rises and falls, more articles admonishing about the inevitable massive stock market 1929-type crash populate investors’ screens.
Generation Investor Should Remain Optimistic
UnitedHealth Shares Gain On Q3 Earnings Beat, Raised FY21 Outlook
UnitedHealth Group Inc (NYSE:UNH) reported Q3 revenues of $72.3 billion, up 11% Y/Y and beating the consensus of $71.19 billion, reflecting…
UnitedHealth Group Q3 Adj. EPS $4.52 Beats $4.41 Estimate, Sales $72.30B Beat $71.19B Estimate
UnitedHealth Group (NYSE:UNH) reported quarterly earnings of $4.52 per share which beat the analyst consensus estimate of $4.41 by 2.49 percent. This is a 28.77 percent increase over earnings of $3.51 per share from the
Earnings Scheduled For October 14, 2021
Companies Reporting Before The Bell
• Domino's Pizza (NYSE:DPZ) is expected to report quarterly earnings at $3.11 per share on revenue of $1.04 billion.
Peloton Pedals to Growth Outside Homes
Peloton Interactive Inc (NASDAQ: PTON) is looking outside homes for its next stage of growth. Back in April, it acquired Precor whose equipment is usually found in commercial settings for $420 million but it is now doing much more in terms of going outside homes.
Analyst Ratings For UnitedHealth Group
UnitedHealth Group (NYSE:UNH) has observed the following analyst ratings within the last quarter:
Why Did SVB Leerink Initiate Humana With Outperform?
While Humana Inc.’s (NYSE: HUM) stock already seems to price in the near-term concerns around rebounding medical costs and high COVID-19 costs, it offers an opportunity to gain exposure to “the post-COVID accelerating growth environment and associated 2022 inflection,” according to SVB Leerin